Highland Capital Management (Tennessee)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
22,239
-24,140
-52% -$1.95M 0.08% 202
2026
Q1
$4.02M Buy
46,379
+2,375
+5% +$228K 0.21% 105
2025
Q4
$4.23M Sell
44,004
-2,640
-6% -$256K 0.21% 111
2025
Q3
$4.44M Buy
46,644
+210
+0.5% +$19.3K 0.22% 107
2025
Q2
$4.05M Sell
46,434
-2,434
-5% -$206K 0.22% 116
2025
Q1
$4.39M Sell
48,868
-1,618
-3% -$145K 0.26% 98
2024
Q4
$4.03M Sell
50,486
-1,194
-2% -$103K 0.23% 112
2024
Q3
$4.65M Sell
51,680
-2,510
-5% -$211K 0.27% 95
2024
Q2
$4.27M Sell
54,190
-2,820
-5% -$231K 0.25% 99
2024
Q1
$4.97M Sell
57,010
-1,529
-3% -$130K 0.29% 92
2023
Q4
$4.82M Buy
+58,539
New +$4.46M 0.3% 95
2023
Q3
Sell
-61,410
Closed -$5.41M 344
2023
Q2
$5.41M Sell
61,410
-1,261
-2% -$109K 0.35% 84
2023
Q1
$5.05M Sell
62,671
-147
-0.2% -$12K 0.37% 79
2022
Q4
$4.88M Sell
62,818
-461
-0.7% -$37.4K 0.34% 85
2022
Q3
$5.11M Sell
63,279
-1,060
-2% -$95.3K 0.39% 64
2022
Q2
$5.77M Buy
64,339
+1
+0% +$101 0.41% 58
2022
Q1
$7.14M Buy
64,338
+33,360
+108% +$3.52M 0.43% 60
2021
Q4
$3.21M Buy
30,978
+472
+2% +$54.7K 0.18% 139
2021
Q3
$3.82M Buy
30,506
+16,014
+111% +$2.07M 0.23% 126
2021
Q2
$1.8M Sell
14,492
-4,065
-22% -$510K 0.11% 194
2021
Q1
$2.19M Sell
18,557
-243
-1% -$28.5K 0.14% 171
2020
Q4
$2.2M Sell
18,800
-9
-0% -$991 0.14% 170
2020
Q3
$1.96M Sell
18,809
-404
-2% -$40.6K 0.14% 166
2020
Q2
$1.76M Buy
19,213
+100
+0.5% +$9.59K 0.14% 164
2020
Q1
$1.72M Buy
19,113
+4,310
+29% +$459K 0.16% 141
2019
Q4
$1.68M Sell
14,803
-10
-0.1% -$1.1K 0.12% 176
2019
Q3
$1.61M Sell
14,813
-395
-3% -$41.2K 0.12% 180
2019
Q2
$1.48M Sell
15,208
-314
-2% -$28.7K 0.11% 191
2019
Q1
$1.41M Hold
15,522
0.11% 189
2018
Q4
$1.41M Sell
15,522
-100
-0.6% -$9.35K 0.12% 172
2018
Q3
$1.54M Sell
15,622
-377
-2% -$34.9K 0.11% 181
2018
Q2
$1.37M Sell
15,999
-141
-0.9% -$11.8K 0.1% 182
2018
Q1
$1.29M Sell
16,140
-839
-5% -$69.2K 0.1% 183
2017
Q4
$1.37M Sell
16,979
-817
-5% -$65.4K 0.1% 171
2017
Q3
$1.38M Hold
17,796
0.11% 169
2017
Q2
$1.58M Sell
17,796
-654
-4% -$55.1K 0.13% 158
2017
Q1
$1.49M Sell
18,450
-977
-5% -$76.3K 0.12% 163
2016
Q4
$1.38M Sell
19,427
-10,271
-35% -$807K 0.12% 173
2016
Q3
$2.57M Sell
29,698
-182
-0.6% -$15.9K 0.22% 124
2016
Q2
$2.59M Sell
29,880
-16,563
-36% -$1.34M 0.22% 121
2016
Q1
$3.48M Sell
46,443
-2,239
-5% -$169K 0.3% 104
2015
Q4
$3.75M Sell
48,682
-536
-1% -$40.3K 0.3% 105
2015
Q3
$3.29M Sell
49,218
-179
-0.4% -$13.2K 0.28% 115
2015
Q2
$3.66M Sell
49,397
-959
-2% -$73.3K 0.28% 109
2015
Q1
$3.93M Buy
50,356
+29,139
+137% +$2.21M 0.77% 51
2014
Q4
$1.53M Hold
21,217
0.29% 82
2014
Q3
$1.31M Hold
21,217
0.26% 80
2014
Q2
$1.35M Buy
21,217
+175
+0.8% +$10.6K 0.25% 83
2014
Q1
$1.29M Buy
21,042
+153
+0.7% +$8.91K 0.25% 82
2013
Q4
$1.2M Buy
20,889
+500
+2% +$28.4K 0.24% 80
2013
Q3
$1.09M Sell
20,389
-563
-3% -$30.3K 0.24% 79
2013
Q2
$1.08M Buy
+20,952
New +$1.04M 0.25% 75

Other funds holding MDT

Highland Capital Management (Tennessee)'s MDT Position: Q2 2026 in Review

Highland Capital Management (Tennessee) reduced its Medtronic (MDT) stake by 52% in Q2 2026, selling an estimated $1.95M and leaving 22,239 shares worth $1.74M. The position accounts for 0.08% of the portfolio, ranked #202.

Highland Capital Management (Tennessee) first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.14M in Q1 2022. 924 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Highland Capital Management (Tennessee) held 22,239 shares of Medtronic worth $1.74M as of Q2 2026.
  • Highland Capital Management (Tennessee) sold 24,140 Medtronic shares in Q2 2026, an estimated $1.95M.
  • Medtronic made up 0.08% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #202 holding.
  • Highland Capital Management (Tennessee) first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Highland Capital Management (Tennessee)'s Medtronic position peaked at $7.14M in Q1 2022.
  • 924 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.